Testing effectiveness (Phase 2)Ended earlyNCT00087269
What this trial is testing
Erlotinib in Treating Patients With Stage I-IIIA Non-Small Cell Lung Cancer Undergoing Surgical Resection
Who this might be right for
Stage IA Non-small Cell Lung CancerStage IB Non-small Cell Lung CancerStage IIA Non-small Cell Lung Cancer+2 more
National Cancer Institute (NCI) 110